These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4928964)

  • 41. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM; Baroni A
    Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract]   [Full Text] [Related]  

  • 42. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 43. [Amandatine hydrochloride (Symmetrel) in the treatment of parkinsonism].
    Nikolić M; Lević Z
    Srp Arh Celok Lek; 1976 Feb; 104(2):113-8. PubMed ID: 1013802
    [No Abstract]   [Full Text] [Related]  

  • 44. Non-resting tremor in Parkinson's disease.
    Schwab RS; Young RR
    Trans Am Neurol Assoc; 1971; 96():305-7. PubMed ID: 5159117
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of Parkinson's disease with amantadine (Symmetrel).
    van Manen J
    Psychiatr Neurol Neurochir; 1972; 75(1):49-59. PubMed ID: 5024896
    [No Abstract]   [Full Text] [Related]  

  • 46. Amantadine hydrochloride in the treatment of parkinsonism: a placebo-controlled double-blind study.
    Freedman BE; Getz E; MacGregor JM; Ames FR
    S Afr Med J; 1971 Apr; 45(16):435-7. PubMed ID: 4932339
    [No Abstract]   [Full Text] [Related]  

  • 47. Parkinsonism as a falling sickness.
    Klawans HL; Topel JL
    JAMA; 1974 Dec; 230(11):1555-7. PubMed ID: 4479664
    [No Abstract]   [Full Text] [Related]  

  • 48. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 49. The antiparkinson properties of amantadine in drug-induced parkinsonism.
    Kelly JT; Abuzzahab FS
    J Clin Pharmacol New Drugs; 1971; 11(3):211-4. PubMed ID: 5211353
    [No Abstract]   [Full Text] [Related]  

  • 50. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
    Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
    [No Abstract]   [Full Text] [Related]  

  • 51. [Long-term effects of amantadine in striatal syndromes].
    Rovetta P
    Minerva Med; 1971 Oct; 62(82):3965-7. PubMed ID: 5125054
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 53. [Amantadine in the treatment of Parkinson's disease].
    Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
    Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
    [No Abstract]   [Full Text] [Related]  

  • 54. [Amantadine in Parkinson's disease].
    Streifler M; Kallay U
    Harefuah; 1972 Jun; 82(11):499-503. PubMed ID: 5068899
    [No Abstract]   [Full Text] [Related]  

  • 55. KR 339 in the treatment of Parkinsonian tremor.
    Iivanainen M
    Acta Neurol Scand; 1974; 50(4):469-77. PubMed ID: 4604665
    [No Abstract]   [Full Text] [Related]  

  • 56. Amantadine hydrochloride in the treatment of Parkinson's disease.
    Nagaswami S; Ranjini R
    J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698
    [No Abstract]   [Full Text] [Related]  

  • 57. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
    Fünfgeld EW
    Munch Med Wochenschr; 1972 Jun; 114(22):1064-5. PubMed ID: 5068021
    [No Abstract]   [Full Text] [Related]  

  • 58. [Data on the therapeutic action of amantadine in parkinsonian syndromes].
    Barone A; Gentile A; Scoleri G
    Minerva Med; 1971 Oct; 62(82):3979-83. PubMed ID: 5125058
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of amantadine in the treatment of parkinsonism].
    D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A
    Minerva Med; 1971 Oct; 62(82):3952-4. PubMed ID: 5125049
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of amantadine in parkinsonism].
    Crudeli R; Candia O
    Minerva Med; 1971 Oct; 62(82):3963-4. PubMed ID: 5125053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.